Prendingue, Leah Joy G.
HRN: 23-14-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2023
CEFUROXIME 1.5GM (VIAL)
06/04/2023
06/04/2023
IVT
1.5g
Prior To OR
For Primary LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes